TY - JOUR A1 - Horn, Lars-Christian A1 - Fischer, Uta A1 - Raptis, Georgios A1 - Bilek, Karin A1 - Hentschel, Bettina T1 - Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer JF - Gynecologic Oncology N2 - Objectives Tumor size is a well recognized prognostic factor in early stage cervical carcinoma (CX). However, limited knowledge exists about the value of tumor size in surgically treated CX with extrauterine extension. Methods 245 cases of local advanced CX (FIGO stage IIA and IIB) who received upfront surgery were evaluated regarding tumor size, regarding the prediction of pelvic lymph node involvement and recurrence free and overall survival during a median follow-up time of 54 months (95% CI 45.4–62.6 months). Tumors larger than 4 cm were defined as bulky stage disease. Results Bulky disease was seen in 46.1% (113/245). 60.2% of these patients showed pelvic lymph node involvement, compared to 42.4% (56/132) in non-bulky tumors (p = 0.006; odds ratio: 2.2 [95% CI: 1.3–3.6]). Patients with bulky tumors showed an increase of recurrent disease (40.2% vs. 28.0%; p = 0.045). The relative risk for recurrent disease was 1.97 (95% CI: 1.3–3.0). The 5-year overall survival rate was significantly lower (67.7% [95% CI: 58.2–74.8] vs. 49.5% [95% CI: 36.8–59.1]; p = 0.0015). In multivariate analysis, tumor stage, pelvic lymph node involvement and maximal tumor size were independent prognostic factors. Conclusions The results suggest that tumor size, defining bulky disease as tumors larger than 4 cm, is of prognostic impact also in FIGO stage II cervical carcinomas. A revised FIGO/TNM classification system similar to the subgrouping of stage IB CX is recommended for stage II using a cut-off value of 4 cm as discriminator: stage IIA1 and stage IIB1 for tumors with ≤ 4 cm and IIA2 and IIB2 for tumors > 4 cm (i.e. bulky disease). KW - Gebärmutterhalskrebs KW - Chirurgie KW - Tumorwachstum Y1 - 2007 U6 - https://doi.org/10.1016/j.ygyno.2007.06.026 VL - 107 IS - 2 SP - 310 EP - 315 ER - TY - CHAP A1 - Höh, H. A1 - Raptis, Georgios T1 - Applications of the Erbium: YAG Laser in Ophthalmology - Cataracta-, Glaukoma-, Eyelid-Surgery and pars plana Vitrectomy BT - Symposium on Cataract, IOL, and Refractive Surgery. Boston, 20.05.2000 und 22.05.2000 N2 - Recent developments in lasers have provided us the possibility of laser ocular surgery. The xenon, argon, neodymium:YAG and dye lasers have been successfully used in out-patient clinics. The excimer laser has been attracting researchers' interest in the new application of laser to cornea and lens. The erbium:YAG laser emits a 2.94-microns beam that can ablate the transparent ocular tissues such as lenses and corneas. The author has applied this laser to the cornea, lens, vitreous and other ocular tissues. The erbium:YAG laser beam was directed through a 1.5-meter-long, 200-microns-diameter fiberoptic guide. The radiant energy measured about 50 mJ at the end of the probe. The laser was emitted as a 400-microsecond pulse. Freshly enucleated rabbit eyes were used in this study. Laser burns were applied to the tissue surface at various energy settings. At minimal power, the tissues were coagulated by the erbium:YAG laser application. At a power of more than 636-954 mJ/mm2, tissue began to evaporate; the tissue loss was observed under a surgical light microscope. Corneal photoablation, lens ablation, iridotomy, trabeculotomy, cutting of the vitreous and retinal ablation were easily performed. Like the excimer laser, the erbium:YAG laser is a potential tool for ocular surgery. KW - Augenchirurgie KW - YAG-Laser KW - Erbium-Laser Y1 - 2000 ER - TY - CHAP A1 - Spychalski, Dominik A1 - Rode, Olaf A1 - Ritthaler, Markus A1 - Raptis, Georgios T1 - Conceptual Design and Analysis of a Mobile Digital Identity for eHealth Applications T2 - 2021 IEEE EMBS International Conference on Biomedical and Health Informatics (BHI): 27-30 July 2021, Athens, Greece N2 - As mobile technology continues to improve, more and more professional services are being offered as mobile apps. This paradigm shift also affects eHealth applications. Digital identities in nation-wide eHealth infrastructures are often realized via smart cards, which however, do not support mobile applications well. In this paper we propose a concept of a mobile eID for eHealth based on smartphones with embedded secure hardware, an mobile authenticator app and an account manager as well as an Identity Provider (IdP) as backend services. The practical applicability of the concept is shown using the example of the German eHealth infrastructure. Our method generates a cryptographic key pair in secure hardware on the user’s smartphone, registers it on the IdP and uses it to authenticate on the IdP. The security of the private key and the integrity of the smartphone is also validated and attestated. The user’s established smartcard-based identity "Electronic Health Card" (EHC) forms the trust anchor. To authenticate against specialist eHealth apps the IdP issues standard-compliant OAuth2.0/OIDC tokens with a limited period of validity. Furthermore, in our security analysis we demonstrate that based on specific security requirements for smartphones and operating systems, at least the eIDAS security level "substantial" related to the technical security aspects of the system can be achieved. On the basis of this research German legislation was adjusted and "digital identities" supplementary to the smartcard-based EHC will be issued from 2023 in the German eHealth infrastructure. KW - digital identity KW - mobile security KW - eHealth KW - authentication scheme KW - identity management Y1 - 2021 U6 - https://doi.org/10.1109/BHI50953.2021.9508554 SN - 2641-3604 SP - 1 EP - 4 PB - IEEE ER - TY - CHAP A1 - Rush, Logan A1 - Schmid, Marina A1 - Raptis, Georgios T1 - Privacy Challenges in Genomic Data: A Scoping Review of Risks, Mitigation Strategies, and Research Gaps. T2 - Information and Communication Technology: 13th International Symposium, SOICT 2024, Danang, Vietnam, December 13–15, 2024, Proceedings, Part II N2 - Advances in genomic research have created new privacy challenges. This scoping review analyzes the risks associated with the processing, storage, and sharing of genomic data including epigenetics, and examines current privacy protection strategies. It also attempts to identify research gaps in this area. Using the PRISMA methodology, 37 relevant studies were identified and analyzed. The results of the risk assessment can be grouped into four main themes: Risks posed by processing of functional genomic data, sharing of genomic data, patient (re-)identification, and dividuality, i.e. the extending of privacy risks to blood relatives. The identified risk mitigation strategies were systematically categorized into five classes: pre-release measures, governance, secure data processing and exchange, access restriction and transparency, anonymization and masking. However, there are some important research gaps that still need to be addressed. The current literature neglects to assess the likelihood of potential breaches and tends to focus only on assessing possible scenarios of privacy risks. It also mainly fails to assess the role of contextualized data and the effectiveness of policies and governance systems with respect to privacy risks. Y1 - 2025 U6 - https://doi.org/10.1007/978-981-96-4285-4_34 SP - 416 EP - 430 PB - Springer CY - Singapore ER - TY - JOUR A1 - Steinhauser, Stefanie A1 - Raptis, Georgios T1 - Design propositions for nudging in healthcare: Adoption of national electronic health recordsystems JF - Digital Health N2 - Objectives: Electronic health records (EHRs) are considered important for improving efficiency and reducing costs of ahealthcare system. However, the adoption of EHR systems differs among countries and so does the way the decision to par-ticipate in EHRs is presented. Nudging is a concept that deals with influencing human behaviour within the research streamof behavioural economics. In this paper, we focus on the effects of the choice architecture on the decision for the adoption ofnational EHRs. Our study aims to link influences on human behaviour through nudging with the adoption of EHRs to inves-tigate how choice architects can facilitate the adoption of national information systems. Methods: We employ a qualitative explorative research design, namely the case study method. Using theoretical sampling,we selected four cases (i.e., countries) for our study: Estonia, Austria, the Netherlands, and Germany. We collected and ana-lyzed data from various primary and secondary sources: ethnographic observation, interviews, scientific papers, homepages,press releases, newspaper articles, technical specifications, publications from governmental bodies, and formal studies. Results: The findings from our European case studies show that designing for EHR adoption should encompass choice archi-tecture elements (i.e., defaults), technical elements (i.e., choice granularity and access transparency), and institutional ele-ments (i.e., regulations for data protection, information campaigns, and financial incentives) in combination. Conclusions: Our findings provide insights on the design of the adoption environments of large-scale, national EHR systems.Future research could estimate the magnitude of effects of the determinants. KW - Health policies KW - national KW - information system KW - multihospital KW - electronic health records KW - doption KW - ealthcare systems Y1 - 2023 U6 - https://doi.org/10.1177/20552076231181208 SN - 2055-2076 VL - 9 SP - 1 EP - 12 PB - Sage ER - TY - GEN A1 - Wolter, Jennifer A1 - Raptis, Georgios A1 - Middel, Luise A1 - Ritthaler, Markus A1 - Loss, J. A1 - Ludwig, Bernd T1 - Requirements for Apps Providing Teleconsultation Services Between Nursing Homes, Home-Based Nursing Care, and Doctors T2 - 2021 IEEE EMBS International Conference on Biomedical and Health Informatics (BHI), 27-30 July 2021, virtual conference Y1 - 2021 N1 - extended abstract & Vortrag PB - IEEE ER - TY - JOUR A1 - Horn, Lars-Christian A1 - Raptis, Georgios A1 - Nenning, Hans T1 - DNA cytometric analysis of surgically treated squamous cell cancer of the uterine cervix, stage pT1b1-pT2b JF - Analytical and quantitative cytology and histology N2 - Objective: To determine the utility of DNA content and DNA-related variables of proliferative activity regarding prognosis in cervical cancer. Study design: DNA image (ICM) andflow cytometry (FCM) were performed to determine the DNA index (DI), 5c-exceeding rate (5c-ER), S-phase fraction (SPF) and proliferation index (PI) in 163 patients with surgically staged pT1b1-pT2b squamous cell cancer of the uterine cervix and treated with primary radical hysterectomy. ICM was performed on imprint cytology, obtained from fresh tumor tissue, which was also used for FCM. Results were analyzed using the chi2 test and Cox regression analysis for risk of pelvic lymph node involvement, tumor recurrence and recurrence-free survival (RFS). Results: ICM was performed on all 163 and FCM on 133 samples. One-third of the tumors showed DNA aneuploidy. Analysis demonstrated prognostic significance of a DI > or = 1.70, with a (70:30) 2.3-fold risk of recurrence (P=.024) and reduced RFS of 10 months (P=.003) in cases of DI > or = 1.70. A high 5c-ER > 11% was associated with pelvic lymph node involvement and decreased RFS (P < or = .04). Significantly more relapses were found in tumors with SPF > 12% (70.8% vs. 29.2%, P=.007). RFS was markedly reduced in tumors with high SPF (52.3 vs. 61.1 months, P=.011). Low proliferative tumors (PI<25%) were associated with lower stage (P=.036) and increased RFS (61.2 vs. 47.1 months, P=.028). In multivariate analysis of clinicopathologic variables (pT category, nodal status, lymphovascular space involvement) and DNA related variables, pelvic lymph node involvement was the only significant predictor of RFS. In patients with nodal involvement, tumors with DI >1.70 were associated with lessfavorable outcomes. Conclusion: DNA-related variables of cell cycle analysis were valuablefor predicting prognosis in cervical cancer patients. Tumors with DI>1.70, 5c-ER >11% and high proliferative activity (SPF>12%, PI>25%) represent a subgroup with a poor prognosis. KW - Gebärmutterhals KW - squamöser Krebs KW - Cytometrie KW - Chirurgie Y1 - 2002 VL - 24 IS - 1 SP - 23 EP - 29 ER - TY - JOUR A1 - Horn, Lars-Christian A1 - Pippig, S. A1 - Raptis, Georgios A1 - Fischer, Uta A1 - Köhler, U. A1 - Hentschel, Bettina A1 - Martin, Rosemarie T1 - Clinical relevance of urokinase-type plasminogen activator and its inhibitor type-1 (PAI-1) in squamous cell carcinoma of the uterine cervix JF - Australian and New Zealand Journal of Obstetrics and Gynaecology N2 - Objective The expression of uPA and PAI‐1 as parameters of tumour‐associated proteolysis has been implicated in the process of tumour cell invasion and the metastatic process. However, there is limited information on the impact of these parameters in cervical carcinoma. Methods Quantitative levels for uPA (n = 114) and PAI‐1 (n = 103) were researched in operatively treated, surgically staged squamous cell cancer of the uterine cervix, using an ELISA‐technique. Results were assessed regarding their impact in predicting pelvic lymph nodes metastases, tumour recurrence rate and recurrence free survival (RFS) using uni‐ and multivariate analysis. Results Median levels of both parameters were significantly higher in tumour tissue than in normal cervical tissue (p < 0.001). Detection of uPA gave no useful prognostic information. PAI‐1 concentration showed a positive correlation with advanced tumour stage (p = 0.008), but no significant correlation with nodal status (pN0: 2.6 vs. pN1: 4.0 ng/mg protein; p = 0.092). Using a cut‐off level of 2.4 ng/mg protein, patients with elevated PAI‐1 levels demonstrated reduced RFS (45.9 versus 52.9 months; p = 0.1). Multivariate analysis, including nodal status, tumour stage, lymphovascular space involvement and grading failed to demonstrate any prognostic impact of uPA and PAI‐1. Conclusions The results indicate, that PAI‐1 expression is of some prognostic impact in cervical cancer, indicating an association of elevated PAI levels with local tumour progression and reduced recurrence‐free survival. KW - Plasminogen human-Aktivator KW - Urokinase KW - squamöser Krebs KW - Gebärmutterhals Y1 - 2004 U6 - https://doi.org/10.1111/j.0004-8666.2002.00385.x VL - 42 IS - 4 SP - 385 EP - 388 ER - TY - JOUR A1 - Horn, Lars-Christian A1 - Raptis, Georgios A1 - Fischer, Uta T1 - Familial cancer history in patients with carcinoma of the cervix uteri JF - European Journal of Obstetrics & Gynecology and Reproductive Biology KW - Gebärmutterhalskrebs KW - Familienanamnese Y1 - 2002 U6 - https://doi.org/10.1016/s0301-2115(01)00520-6 VL - 101 IS - 1 SP - 54 EP - 57 ER - TY - JOUR A1 - Horn, Lars-Christian A1 - Fischer, Uta A1 - Hanel, C. A1 - Kuhn, H. A1 - Raptis, Georgios A1 - Bilek, Karin T1 - p53 in surgically treated and pathologically staged cervical cancer BT - correlation with local tumor progression, but not with lymphatic spread JF - Pathology - Research and Practice KW - Gebärmutterhalskrebs KW - Tumorsuppressor-Gen KW - Chirurgie KW - Histopathologie Y1 - 2001 VL - 197 IS - 9 SP - 605 EP - 609 ER - TY - CHAP A1 - Raptis, Georgios ED - Wetter, Thomas T1 - Privacy and Data Protection: Mission Impossible? T2 - Consumer Health Informatics N2 - Medical confidentiality is very important because it builds the fundament of trust between doctors and patients. In modern health services data protection is essential. But there are also other important security objectives, such as integrity and authenticity of medical data and health services, as their breach can potentially lead to life threatening conditions. State of the art security mechanisms are necessary to protect medical data and services and prevent attacks known as “hacking”. They should include in particular cryptography, as you can usually rely on mathematics, more than in software security and access control mechanisms. As patients normally cannot assess the security of a service, security audits or certifications of health services should be provided to generate trust and confidence. KW - Gesundheitswesen KW - Medizinische Versorgung KW - Datenschutz KW - Datensicherung Y1 - 2016 SN - 978-3-319-19589-6 U6 - https://doi.org/10.1007/978-3-319-19590-2 SP - 273 EP - 280 PB - Springer International Publishing ER - TY - JOUR A1 - Horn, Lars-Christian A1 - Raptis, Georgios A1 - Fischer, Uta A1 - Bilek, Karin T1 - Standardised handling of hysterectomy specimen in cervical cancer – report of over 900 stage pT1b1- to pT2b-tumors JF - Pathology - Research and Practice KW - Gebärmutterhalskrebs KW - Chirurgie KW - Gewebe KW - Gebärmutterentfernung Y1 - 2000 VL - 196 SP - 450 ER - TY - JOUR A1 - Horn, Lars-Christian A1 - Raptis, Georgios A1 - Fischer, Uta A1 - Bilek, Karin T1 - Impact of tumorload in surgically treated, histologically staged early cervical cancer: Multivariate analysis of 568 patients JF - International Journal of Gynecology & Obstetrics KW - Gebärmutterhalskrebs KW - Chirurgie KW - Tumorklasifikation Y1 - 2000 VL - 70 IS - Suppl. 1 SP - 20 EP - 21 ER - TY - JOUR A1 - Horn, Lars-Christian A1 - Raptis, Georgios A1 - Fischer, Uta A1 - Bilek, Karin T1 - p53-tumorsuppressor gene in surgically treated histologically staged early cervical cancer JF - International Journal of Gynecology & Obstetrics KW - Tumorsuppressor-Gen KW - Chirurgie KW - Histopathologie KW - Gebärmutterhalskrebs Y1 - 2000 VL - 70 IS - Suppl. 1 SP - 112 ER - TY - JOUR A1 - Lekakis, J. A1 - Nanas, J. A1 - Prassopoulos, V. A1 - Raptis, Georgios T1 - Cardiac I-123 metaiodobenzylguanidine uptake in predicting early and late mortality in patients with congestive heart failure JF - Circulation (Suppl.) KW - Stauungssuffizienz KW - Radiologische Diagnostik KW - Prognose Y1 - 1997 VL - 96 IS - 8 SP - 2104 ER - TY - JOUR A1 - Horn, Lars-Christian A1 - Fischer, Uta A1 - Tannapfel, A. A1 - Kuhn, H. A1 - Hänel, C. A1 - Raptis, Georgios T1 - The role of p53 tumorsuppressorgene in tumor progression in cervical cancer JF - Pathology - Research and Practice KW - Tumorsuppressor-Gen KW - Tumorwachstum KW - Gebärmutterhalskrebs Y1 - 1999 VL - 195 SP - 328 ER - TY - GEN A1 - Horn, L. C A1 - Pippig, S. A1 - Raptis, Georgios A1 - Fischer, Uta A1 - Kohler, U. A1 - Hentschel, Bettina A1 - Martin, Rosemarie T1 - 00083 PAI-1 AND UFA AS PARAMETERS OF TUMORASSOCIATED PROTEOLYSIS IN CERVICAL CARCINOMA T2 - International Journal of Gynecologic Cancer Y1 - 2005 U6 - https://doi.org/10.1136/ijgc-00009577-200509001-00083 SN - 1048-891X VL - 15 IS - Suppl 2 EP - 74 PB - BMJ ER - TY - JOUR A1 - Schedlbauer, Jürgen A1 - Raptis, Georgios A1 - Ludwig, Bernd T1 - Medical informatics labor market analysis using web crawling, web scraping, and text mining JF - International Journal of Medical Informatics N2 - Objectives The European University Association (EUA) defines “employability” as a major goal of higher education. Therefore, competence-based orientation is an important aspect of education. The representation of a standardized job profile in the field of medical informatics, which is based on the most common labor market requirements, is fundamental for identifying and conveying the learning goals corresponding to these competences. Methods To identify the most common requirements, we extracted 544 job advertisements from the German job portal, STEPSTONE. This process was conducted via a program we developed in R with the “rvest” library, utilizing web crawling, web extraction, and text mining. After removing duplicates and filtering for jobs that required a bachelor's degree, 147 job advertisements remained, from which we extracted qualification terms. We categorized the terms into six groups: professional expertise, soft skills, teamwork, processes, learning, and problem-solving abilities. Results The results showed that only 45% of the terms are related to professional expertise, while 55% are related to soft skills. Studies of employee soft skills have shown similar results. The most prevalent terms were programming, experience, project, and server. Our second major finding is the importance of experience, further underlining how essential practical skills are. Conclusions Previous studies used surveys and narrative descriptions. This is the first study to use web crawling, web extraction, and text mining. Our research shows that soft skills and specialist knowledge carry equal weight. The insights gained from this study may be of assistance in developing curricula for medical informatics. KW - Medical informatics KW - Graduate employability KW - Text mining KW - Competence-based education KW - Soft skills Y1 - 2021 U6 - https://doi.org/10.1016/j.ijmedinf.2021.104453 SN - 1386-5056 VL - 150 IS - June PB - Elsevier ER - TY - JOUR A1 - Dotter, Caroline A1 - Haug, Sonja A1 - Schnell, Rainer A1 - Raptis, Georgios A1 - Weber, Karsten T1 - Sharing health data for research purposes: results of a population survey in Germany JF - BMC health services research N2 - BACKGROUND: Increased use of health data has the potential to improve both health care and health policies. Several recent policy initiatives at the European and German legislative levels aim to increase the primary and secondary use of health data. However, little is known about general population views on health data access for research. Most studies are based on subsets defined by specific illnesses. METHODS: We commissioned a national computer-assisted dual-frame telephone survey (landline and mobile). Logit estimation models were used to identify predictors of willingness to provide access to health data to different organizations (universities in Germany, universities worldwide, German government organizations, pharmaceutical companies). RESULTS: A high willingness to share health data for research purposes is observed, depending on the specific data recipient. The willingness is highest for research at universities in Germany and German governmental organizations, and lowest regarding research by pharmaceutical companies. The main drivers for sharing health data are the level of trust in public institutions, the respondents' assessment of the seriousness and likelihood of data misuse, and the level of digital literacy. Age, gender, and level of education have small effects and do not determine the willingness to share health data for all organizations. CONCLUSION: We present evidence from a random sample of the German population. The results indicate widespread support among the population for providing access to health data for research purposes. Similar to findings in other countries, the willingness depends strongly on the recipient of the data. This paper evaluates the impact of various determinants - identified in previous qualitative and quantitative research - on the willingness of the German population to share health data. While previous studies have found that patients are generally more willing to share health data, we found that the presence of a medical precondition does not translate into respondents' unequivocal support for health data sharing. We identify privacy concerns, general trust, and digital literacy as key factors influencing the willingness to share health data. Therefore, policymakers and stakeholders need to ensure and communicate the necessary privacy protection measures to increase the willingness of the German population to share health data. Y1 - 2025 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:898-opus4-81622 N1 - Corresponding author der OTH Regensburg: Caroline Dotter VL - 25 PB - BMC ER - TY - JOUR A1 - Winter, Lina A1 - Artinger, Annalena A1 - Böck, Hendrik A1 - Ramakrishnan, Vignesh A1 - Reible, Bruno A1 - Albin, Jan A1 - Schüffler, Peter J. A1 - Raptis, Georgios A1 - Brochhausen, Christoph T1 - Developing a smart and scalable tool for histopathological education—PATe 2.0 JF - Journal of Pathology Informatics N2 - Digital microscopy plays a crucial role in pathology education, providing scalable and standardized access to learning resources. In response, we present PATe 2.0, a scalable redeveloped web-application of the former PATe system from 2015. PATe 2.0 was developed using an agile, iterative process and built on a microservices architecture to ensure modularity, scalability, and reliability. It integrates a modern web-based user interface optimized for desktop and tablet use and automates key workflows such as whole-slide image uploads and processing. Performance tests demonstrated that PATe 2.0 significantly reduces tile request times compared to PATe, despite handling larger tiles. The platform supports open formats like DICOM and OpenSlide, enhancing its interoperability and adaptability across institutions. PATe 2.0 represents a robust digital microscopy solution in pathology education enhancing usability, performance, and flexibility. Its design enables future integration of research algorithms and highlights it as a pivotal tool for advancing pathology education and research. Y1 - 2026 U6 - https://doi.org/10.1016/j.jpi.2025.100535 SN - 2153-3539 VL - 20 PB - Elsevier ER - TY - INPR A1 - Cenko, Egidia A1 - Weimann, Thure Georg A1 - Raptis, Georgios T1 - Navigating the DiGA Jungle: A Taxonomy and Archetypal Framework of the German Digital Therapeutics Landscape N2 - Digital therapeutics (DTx) are patient-facing apps designed to support individuals in their daily lives. Therefore, they have thepotential to revolutionize healthcare by empowering and engaging patients to become active players in their own care. Despitethe increasing adoption of DTx in national healthcare systems, research on their design remains limited. The present studyintroduces “DiGATax”, a taxonomy designed to categorize and analyze DTx, including perspectives on content, interventiondelivery logic and technology, as well as the patient’s interface, consolidating and expanding upon prior taxonomic work.Based on n = 44 applications retrieved from the German DiGA directory that demonstrated positive health outcomes, thetaxonomy is supported by empirical evidence. Additionally, the study contributes by presenting an archetype frameworkof DTx derived from a taxonomy-based cluster analysis. Further analyses offer insights into specific combinations of DTxcharacteristics across archetypes, the user interface as a key factor in their acceptance, and potential links between DTxdesign and health-related and user engagement outcomes. By offering new insights into DTx design, this study contributestowards more organized research and reporting, ultimately paving the way for the development of effective solutions. It alsomarks a further step towards Meta-DTx, which aim to align patient care for multimorbid patients under one umbrella. KW - Archetypes KW - Digital Behavior Change Interventions KW - Digital Therapeutics KW - mHealth KW - Taxonomy Y1 - 2025 U6 - https://doi.org/10.64898/2025.12.30.25343225 ER -